Crispr Therapeutics Ag (CRSP) SEC Filings — 2025
10 SEC filings for Crispr Therapeutics Ag (CRSP) in 2025.
Filings
- CRISPR Therapeutics' Net Loss Widens to $451M Amid R&D Shifts — 10-Q · Nov 10, 2025
- CRISPR Therapeutics Files 8-K — 8-K · Oct 15, 2025
- CRISPR Revenue Plunges 90% Amid Vertex Collaboration Shift — 10-Q · Aug 4, 2025
- CRISPR Therapeutics Announces New Gene Therapy Collaboration — 8-K · Jun 26, 2025
- CRISPR Therapeutics AG Files 8-K — 8-K · Jun 9, 2025
- CRISPR Therapeutics AG Files 8-K Report — 8-K · May 19, 2025
- CRISPR Therapeutics AG Files Q1 2025 10-Q — 10-Q · May 6, 2025
- CRISPR Therapeutics AG Executive Compensation Filing — DEF 14A · Apr 16, 2025
- CRISPR Therapeutics AG Files 8-K for Officer/Director Changes — 8-K · Mar 26, 2025
- Crispr Therapeutics Ag 10-K Filing — 10-K · Feb 11, 2025